Understanding risk communication through patient narratives about complex antithrombotic therapies

Dorothy C. Andreas, Neena Susan Abraham, Aanand D. Naik, Richard L. Street, Barbara F. Sharf

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The purpose of this study was to explore how patients use narratives to create coherent understandings of risks associated with complex antithrombotic therapies. We led four focus groups consisting of patients older than 65 years of age who had a diagnosis of cardiovascular disease and were using a prescription for cardioprotective agents, such as aspirin, anticoagulants, and/or antiplatelets. The participants' stories were retrospective accounts about physician and patient interactions and adverse events organized in the plot structure of a trial-and-error story. The trial-and-error narrative structure emphasizes patients' idiosyncrasies and reasons why they expect to experience adverse events from changes in treatment. Any fears that they might have had about these risks were mitigated by physician expertise, patient responsibility, and medical technology. Patients who expressed concern about not having sufficient access to medical expertise (e.g., physicians, laboratory tests) seemed less willing to accept risks. The trial-and-error risk narratives helped patients deal with ambiguity and uncertainty about the outcomes of their therapies, and revealed patients' orientations to the risks they faced.

Original languageEnglish (US)
Pages (from-to)1155-1165
Number of pages11
JournalQualitative Health Research
Volume20
Issue number8
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Communication
Therapeutics
Physicians
Cardiotonic Agents
Focus Groups
Anticoagulants
Aspirin
Uncertainty
Fear
Prescriptions
Cardiovascular Diseases
Technology

Keywords

  • communication
  • heart health
  • narrative analysis
  • risk

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Understanding risk communication through patient narratives about complex antithrombotic therapies. / Andreas, Dorothy C.; Abraham, Neena Susan; Naik, Aanand D.; Street, Richard L.; Sharf, Barbara F.

In: Qualitative Health Research, Vol. 20, No. 8, 08.2010, p. 1155-1165.

Research output: Contribution to journalArticle

Andreas, Dorothy C. ; Abraham, Neena Susan ; Naik, Aanand D. ; Street, Richard L. ; Sharf, Barbara F. / Understanding risk communication through patient narratives about complex antithrombotic therapies. In: Qualitative Health Research. 2010 ; Vol. 20, No. 8. pp. 1155-1165.
@article{fe529403261848fd962503a4594da68a,
title = "Understanding risk communication through patient narratives about complex antithrombotic therapies",
abstract = "The purpose of this study was to explore how patients use narratives to create coherent understandings of risks associated with complex antithrombotic therapies. We led four focus groups consisting of patients older than 65 years of age who had a diagnosis of cardiovascular disease and were using a prescription for cardioprotective agents, such as aspirin, anticoagulants, and/or antiplatelets. The participants' stories were retrospective accounts about physician and patient interactions and adverse events organized in the plot structure of a trial-and-error story. The trial-and-error narrative structure emphasizes patients' idiosyncrasies and reasons why they expect to experience adverse events from changes in treatment. Any fears that they might have had about these risks were mitigated by physician expertise, patient responsibility, and medical technology. Patients who expressed concern about not having sufficient access to medical expertise (e.g., physicians, laboratory tests) seemed less willing to accept risks. The trial-and-error risk narratives helped patients deal with ambiguity and uncertainty about the outcomes of their therapies, and revealed patients' orientations to the risks they faced.",
keywords = "communication, heart health, narrative analysis, risk",
author = "Andreas, {Dorothy C.} and Abraham, {Neena Susan} and Naik, {Aanand D.} and Street, {Richard L.} and Sharf, {Barbara F.}",
year = "2010",
month = "8",
doi = "10.1177/1049732310370154",
language = "English (US)",
volume = "20",
pages = "1155--1165",
journal = "Qualitative Health Research",
issn = "1049-7323",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Understanding risk communication through patient narratives about complex antithrombotic therapies

AU - Andreas, Dorothy C.

AU - Abraham, Neena Susan

AU - Naik, Aanand D.

AU - Street, Richard L.

AU - Sharf, Barbara F.

PY - 2010/8

Y1 - 2010/8

N2 - The purpose of this study was to explore how patients use narratives to create coherent understandings of risks associated with complex antithrombotic therapies. We led four focus groups consisting of patients older than 65 years of age who had a diagnosis of cardiovascular disease and were using a prescription for cardioprotective agents, such as aspirin, anticoagulants, and/or antiplatelets. The participants' stories were retrospective accounts about physician and patient interactions and adverse events organized in the plot structure of a trial-and-error story. The trial-and-error narrative structure emphasizes patients' idiosyncrasies and reasons why they expect to experience adverse events from changes in treatment. Any fears that they might have had about these risks were mitigated by physician expertise, patient responsibility, and medical technology. Patients who expressed concern about not having sufficient access to medical expertise (e.g., physicians, laboratory tests) seemed less willing to accept risks. The trial-and-error risk narratives helped patients deal with ambiguity and uncertainty about the outcomes of their therapies, and revealed patients' orientations to the risks they faced.

AB - The purpose of this study was to explore how patients use narratives to create coherent understandings of risks associated with complex antithrombotic therapies. We led four focus groups consisting of patients older than 65 years of age who had a diagnosis of cardiovascular disease and were using a prescription for cardioprotective agents, such as aspirin, anticoagulants, and/or antiplatelets. The participants' stories were retrospective accounts about physician and patient interactions and adverse events organized in the plot structure of a trial-and-error story. The trial-and-error narrative structure emphasizes patients' idiosyncrasies and reasons why they expect to experience adverse events from changes in treatment. Any fears that they might have had about these risks were mitigated by physician expertise, patient responsibility, and medical technology. Patients who expressed concern about not having sufficient access to medical expertise (e.g., physicians, laboratory tests) seemed less willing to accept risks. The trial-and-error risk narratives helped patients deal with ambiguity and uncertainty about the outcomes of their therapies, and revealed patients' orientations to the risks they faced.

KW - communication

KW - heart health

KW - narrative analysis

KW - risk

UR - http://www.scopus.com/inward/record.url?scp=77954932779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954932779&partnerID=8YFLogxK

U2 - 10.1177/1049732310370154

DO - 10.1177/1049732310370154

M3 - Article

C2 - 20442345

AN - SCOPUS:77954932779

VL - 20

SP - 1155

EP - 1165

JO - Qualitative Health Research

JF - Qualitative Health Research

SN - 1049-7323

IS - 8

ER -